Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

BioPorto – Presentation of Half-Year Report 2023

By HC Andersen Capital
BioPorto

Meet and ask questions to BioPorto CEO Tony Pare and CFO Neil Goldman on Tuesday 1 August at 2.00 PM CEST when they present the financial results for the first six months of 2023 along with the latest development for the NGAL Test and the outcome of the rights issue successfully completed in June 2023.

Disclaimer: HC Andersen Capital receives payment from Bioporto for a Digital IR/Corporate Visibility subscription agreement. /ANALYST Claus Thestrup 15:15 PM 5 July 2023.

Recent videos

Investor Day | Nov. 24, 2025
23.12.2025, 11.00 United Bankers
HCA Morgenbørs 23/12 - Flade futures og fokus på Novo Nordisk og Ørsted
23.12.2025, 09.27 Novo Nordisk
HCA Morgenbørs 22/12 - Positiv stemning i Asien og amerikanske futures i plus, mens Europa er fladt
22.12.2025, 09.28 GomSpace Group
HCA Morgenbørs 19/12 - Små fald i den europæiske åbning og fokus på flere danske aktier
19.12.2025, 09.25 Aquaporin
Talenom - Planned demerger and strategies of Talenom and Easor
18.12.2025, 11.00 Talenom
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.